Dear Colleagues, We are happy to invite you to the 9th meeting of Pharmacometrics Network Benelux.
Please mark the following date and time in your agenda: When: Thursday, November 24th 2016 - 12:00 - 18:00 Where: hosted by Ablynx NV, Belgium Technologiepark, 21 9052 Gent/Zwijnaarde Agenda theme: "A special student session" Registration: you can register by sending an e-mail to anne.broc...@ablynx.com<mailto:anne.broc...@ablynx.com>. There is no registration fee, but registration is required for participation. You can register until November 18th. Scientific Program 12.00 - 13.00: Light lunch 13.00 - 13.15: Welcome 13.15 - 13.45: Understanding pharmacokinetics and target binding kinetics using the rate-limiting step approximation Wilbert de Witte, PhD student Leiden University (Netherlands) 13.45 - 14.15: Pharmacokinetics and Pharmacodynamics of hyperthermic intraperitoneal oxaliplatin in peritoneal carcinomatosis patients Carlos Pérez-Ruixo, PhD, Post-Doctoral Researcher Janssen (Belgium) 14.15 - 14.45: First-pass and systemic CYP3A-mediated clearance of midazolam in preterm neonates Jantine Brussee, PhD student Leiden University (Netherlands) 14.45 - 15.30: Coffee/Tea Break 15.30 - 16.00: Population pharmacokinetic analysis of perioperative factor IX dosing in hemophilia B - Preliminary results Tim Preijers, PhD student University of Amsterdam (Netherlands) 16.00 - 16.30: In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation and Precipitation of Posaconazole: Exploring the PBPK modeling platform Simcyp® Bart Hens, PhD KU Leuven (Belgium) 16.30 - 17.00: Sequential PK/PD analysis of the antidiuretic desmopressin in children Robin Michelet, PhD student Ghent University (Belgium) 17.00 - 18.30: Closure followed by reception We hope to see you in Gent on November 24th! Anne Brochot Eugène Cox Thomas Kerbush Charlotte van Kesteren Ron Mathôt Stefaan Rossenu Laura Sargentini On Pharmacometrics Network Benelux: the initiative aims to connect pharmacometricians in the Benelux (Belgium, Netherlands, and Luxembourg). The intention is to create an informal platform for the pharmacometrics community in this region of the world (in industry, academia, hospital pharmacies as well as regulatory bodies), with the goal to promote professional and scientific awareness and interactions. ________________________________________ THIS E-MAIL MESSAGE IS INTENDED ONLY FOR THE USE OF THE INDIVIDUAL OR ENTITY TO WHICH IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL AND EXEMPT FROM DISCLOSURE. If the reader of this E-mail message is not the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify us immediately at abl...@ablynx.com. Thank you for your co-operation. "NANOBODY" and "NANOCLONE" are registered trademarks of Ablynx N.V. ________________________________________
